A Randomised, Double-blind, Placebo-controlled, Multicentre Trial Exploring the Efficacy and Safety of Intra-nasal Administration of FE 202767 in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production

Trial Profile

A Randomised, Double-blind, Placebo-controlled, Multicentre Trial Exploring the Efficacy and Safety of Intra-nasal Administration of FE 202767 in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Merotocin (Primary)
  • Indications Lactation failure
  • Focus Therapeutic Use
  • Acronyms Mermaid
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 10 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 20 Nov 2017.
    • 09 May 2016 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
    • 09 May 2016 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top